Biomedical Research and Therapy
Scope & Guideline
Transforming research into impactful therapies for tomorrow.
Introduction
Aims and Scopes
- Stem Cell Research and Regenerative Medicine:
The journal frequently publishes studies on the isolation, application, and therapeutic potential of stem cells, particularly mesenchymal stem cells, in various medical conditions, highlighting innovative techniques for stem cell therapy. - Cancer Biology and Treatment:
There is a strong emphasis on research related to cancer, including novel therapeutic strategies, biomarker identification, and case studies that explore the complexity of cancer treatment and management. - Immunology and Infectious Diseases:
Research in this journal often addresses the immune response to infections, vaccine development, and the role of immunotherapy in combating diseases, reflecting a growing interest in understanding host-pathogen interactions. - Genetics and Molecular Biology:
The journal explores the genetic basis of diseases, including polymorphism studies and molecular mechanisms, providing insights into potential genetic therapies and personalized medicine. - Nutritional and Metabolic Health:
The journal also investigates the links between nutrition, metabolism, and health outcomes, with studies focusing on dietary patterns, metabolic disorders, and their implications for disease prevention and management. - Clinical Case Reports and Observational Studies:
A significant portion of the journal's content is dedicated to clinical case reports and observational studies, which provide valuable insights into real-world patient management and treatment outcomes.
Trending and Emerging
- Immunotherapy and Cancer Treatment:
There is a growing trend towards research on immunotherapy, including checkpoint inhibitors and novel vaccine designs, which represent cutting-edge approaches in the fight against cancer and infectious diseases. - Microbiome Research:
Studies exploring the role of the gut microbiome in health and disease, particularly its influence on cancer outcomes and metabolic health, are becoming increasingly prominent, highlighting the interconnectedness of gut health and systemic diseases. - Personalized and Precision Medicine:
Research focused on genetic predispositions, biomarkers, and personalized treatment strategies is on the rise, reflecting a broader trend towards tailoring medical treatments to individual patient profiles. - Nanotechnology in Medicine:
The use of nanotechnology for drug delivery and therapeutic applications is gaining traction, as evidenced by the increasing number of studies exploring its potential advantages in enhancing treatment efficacy and reducing side effects. - Regenerative Medicine and Tissue Engineering:
Emerging studies are increasingly focusing on the application of regenerative medicine techniques, including the use of biomaterials and stem cells for tissue repair and healing, indicating a shift towards innovative therapeutic approaches.
Declining or Waning
- Traditional Pharmacology:
Research focusing solely on traditional pharmacological approaches appears to be waning, with fewer studies dedicated to the development of conventional drugs without integrating modern techniques or genetic insights. - Basic Science Without Clinical Relevance:
There is a noticeable decline in studies that do not directly translate to clinical applications or therapeutic strategies, as the journal increasingly favors research with direct implications for patient care. - Animal Studies Without Human Correlation:
The frequency of purely animal model studies is decreasing, with a shift towards research that bridges findings from animal studies to human applications, reflecting the journal's focus on translational research.
Similar Journals
Journal of Translational Medicine
Bridging Discovery and Healing.Journal of Translational Medicine, published by BMC in the United Kingdom, stands at the forefront of biomedical research, bridging the gap between laboratory discoveries and clinical applications. Established in 2003 as an Open Access journal, it has garnered significant recognition, achieving a Q1 quartile ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023. With an impressive Scopus rank of 38 out of 636 in General Medicine and 33 out of 221 in General Biochemistry, Genetics and Molecular Biology, the journal is committed to disseminating high-quality, peer-reviewed research that impacts healthcare and informs clinical practices. By facilitating free access to groundbreaking studies, the Journal of Translational Medicine aims to enhance collaboration among researchers, professionals, and students in the scientific community, fostering advancements in translational research well into the future.
Asian Biomedicine
Pioneering Insights in Biochemistry and GeneticsAsian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.
Cell Reports Medicine
Exploring the nexus of biochemistry and clinical practice.Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.
Genes & Diseases
Exploring the molecular pathways of health and illness.Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.
MOLECULAR MEDICINE
Empowering Research through Open Access InsightsMOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.
Cell and Bioscience
Empowering Knowledge Sharing in Molecular BiologyCell and Bioscience is a prestigious open-access journal published by BMC that has been at the forefront of biochemistry, genetics, and molecular biology since its inception in 2011. With an impressive impact factor, this journal has established itself as a vital resource for researchers and professionals in these rapidly advancing fields, reflecting its high ranking of #29 out of 221 in the Scopus classification and placing it in the 87th percentile. Based in the United Kingdom, Cell and Bioscience aims to foster innovation and dissemination of research findings addressing critical biological questions through rigorous peer-reviewed articles and inter-disciplinary approaches. The journal's open-access model ensures unrestricted access to transformative research, promoting collaboration and knowledge sharing among academics, students, and practitioners worldwide. With a commitment to maintaining excellence in the field, Cell and Bioscience provides an essential platform for those looking to contribute to the evolving landscape of biosciences.
Journal of Biomedical Research
Exploring the Intersection of Biochemistry and MedicineJournal of Biomedical Research, published by Nanjing Medical University in China, is a prominent platform for groundbreaking discoveries in the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine. With an ISSN of 1674-8301 and an E-ISSN of 1876-4819, the journal offers a vital opportunity for researchers, professionals, and students to disseminate insightful research findings. Although not currently available as an open access journal, its inclusion in the second quartile of both Biochemistry and Medicine categories underscores its growing influence and commitment to high-quality scholarship, as evidenced by its historical compliance with Scopus rankings prior to 2009. By fostering an interdisciplinary approach, the Journal of Biomedical Research aims to bridge gaps in current biomedical understanding and encourages innovative research that can lead to significant contributions in improving health outcomes. Its editorial policies guarantee rigorous peer review, making it a trusted source of knowledge in the biomedical community.
Biomedical Reports
Exploring the frontiers of biochemistry and genetics.Biomedical Reports, published by SPANDIDOS PUBL LTD in Greece, is a distinguished open-access journal that focuses on the dynamic fields of biochemistry, genetics, molecular biology, medicine, pharmacology, and neuroscience. Established in 2014, the journal has rapidly gained recognition, securing Q2 and Q3 rankings in several categories for 2023, including a notable ranking of #125/636 in General Medicine, placing it in the 80th percentile amongst its peers. The journal continually aims to disseminate innovative research findings that advance the understanding of complex biomedical issues, making it an invaluable resource for researchers, professionals, and students alike. Its multidisciplinary approach not only reflects the interconnectivity of modern biomedical sciences but also promotes collaborative discourse among diverse fields, ensuring ongoing relevance and impact within the scientific community.
Molecular Medicine Reports
Connecting Researchers for a Healthier TomorrowMolecular Medicine Reports, an esteemed academic journal published by Spandidos Publications Ltd, serves as a vital platform for the dissemination of cutting-edge research in the field of molecular medicine. Established in 2008, this journal has rapidly ascended in prominence, currently positioned within the Q2 and Q3 quartiles across various critical categories including Biochemistry, Cancer Research, and Genetics, reflecting its significant impact and scholarly contributions. With an impressive Scopus ranking in multiple disciplines, including an 87th place in Oncology, it is recognized for publishing rigorous, peer-reviewed articles that bridge the gap between laboratory research and clinical applications. The journal’s commitment to advancing knowledge in molecular medicine is evident through its focus on innovative therapeutic approaches, genetic research, and oncological studies, catering to a diverse readership of researchers, professionals, and students in the biomedical field. Though not an open-access publication, it provides invaluable insights and fosters collaboration in the scientific community from its base in Athens, Greece.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
Exploring Innovations in Experimental Biology and MedicineBULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE is a prestigious journal published by SPRINGER, dedicated to advancing knowledge in the fields of biochemistry, genetics, molecular biology, and medicine. Established in 1956 and continuing to be relevant through to 2024, this journal provides a vital platform for researchers to publish original findings and significant reviews that contribute to these essential disciplines. With an ISSN of 0007-4888 and an E-ISSN of 1573-8221, it enjoys a respectable standing in the academic community, currently positioned in the Q3 quartile of both Biochemistry, Genetics and Molecular Biology, and Medicine categories for 2023. Despite its traditional subscription model, the journal reaches a wide audience of professionals, students, and researchers, who benefit from timely access to impactful research and experimental studies. By fostering a rich dialogue in experimental biology and medicine, this journal plays an important role in shaping ongoing research and understanding of complex biological systems.